To determine the functional consequences of truncating C-terminal FZD2 mutations observed in AD-RS/OMOD2 patients, we used CRISPR/Cas9 gene editing to generate a disruption in mouse Fzd2. This evidence concerns the gene FZD2 and autosomal dominant omodysplasia.